We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Immunochromatography Tests Evaluated for Detection of Novel Norovirus

By LabMedica International staff writers
Posted on 02 Aug 2015
Print article
Image: Transmission electron micrograph (TEM) of norovirus virions, or virus particles (Photo courtesy of Charles D. Humphrey/CDC).
Image: Transmission electron micrograph (TEM) of norovirus virions, or virus particles (Photo courtesy of Charles D. Humphrey/CDC).
A novel GII.17 Norovirus has emerged as a major cause of epidemic and endemic acute gastroenteritis in several countries in Asia.

From September 2014 to March 2015, 70% of all outbreaks in Guangdong and Jiangsu provinces in China were caused by a novel GII.17 virus and a similar increase in the number of infections with this novel GII.17 virus has been reported in Japan and Thailand since December 2014.

Microbiologists at Chiang Mai University (Thailand) working with colleagues from Japan, analyzed randomly selected stool samples for which there was a large quantity available—a panel of six GII.17-positive stool samples from five patients in Japan and one in Thailand in which the virus copy numbers had been quantified by real-time reverse-transcriptase polymerase chain reaction (RT-PC R) for reference values. Two of the six GII.17 stool samples tested positive by four immunochromatography (IC) kits.

To evaluate if these IC tests are able to detect these novel GII.17 noroviruses, they tested four commercial kits available in Japan: GE test Noro Nissui (Nissui Pharmaceutical Co., Ltd.; Tokyo, Japan); ImmunoCatch-Noro (Eiken Chemical Co., Ltd.; Tokyo, Japan); Quick Navi-Noro 2 (Denka Seiken Co., Ltd.; Tokyo, Japan); Quick Chaser-Noro (Mizuho Medy Co., Ltd.; Tosu City, Japan).

The six specimens tested by real-time RT-PCR demonstrated that the two samples that were positive by IC test contained high virus titers of 1.90 × 109 and 8.06 × 109 virus copies/mL. In contrast, the other four specimens that were negative in the IC test had virus titers ranging from 4.91 × 103 to 2.50 ×108 virus copies/mL. The results demonstrated that at 1:10 dilution of a virus titer equal to 1.90 × 108 copies/mL, two of three tests still showed the positive results, with a weak positive band, while at 1:100 dilution equal to virus titer 1.90 × 107 copies/mL, all three IC tests were negative. These data demonstrated that the sensitivity of the IC kits for the detection of this novel GII.17 virus was about 108 copies/mL.

The authors concluded that the tested commercial IC kits for the detection Norovirus available on the market in Japan were able to detect the novel GII.17 Norovirus, but with relatively low sensitivity. Only samples that contained more than 109 copies/mL were positive in all four IC tests. They suggest a redesign of the currently available Norovirus IC tests may be required to detect the novel GII.17 noroviruses with the same sensitivity as for the more commonly circulating norovirus genotypes. Laboratories and physicians should be aware of these findings, in particular where the novel GII.17 norovirus has been shown to be circulating.

Related Links:

Chiang Mai University
Nissui Pharmaceutical 
Eiken Chemical 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.